Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury.
DeFilippis AP, Chapman AR, Mills NL, de Lemos JA, Arbab-Zadeh A, Newby LK, Morrow DA.
Circulation. 2019 Nov 12;140(20):1661-1678. doi: 10.1161/CIRCULATIONAHA.119.040631. Epub 2019 Aug 16.
Type 2 myocardial infarction: challenges in diagnosis and treatment.
Chapman AR, Taggart C, Boeddinghaus J, Mills NL, Fox KAA.
Eur Heart J. 2025 Feb 7;46(6):504-517. doi: 10.1093/eurheartj/ehae803.
Type 2 Myocardial Infarction: JACC Review Topic of the Week.
Sandoval Y, Jaffe AS.
J Am Coll Cardiol. 2019 Apr 16;73(14):1846-1860. doi: 10.1016/j.jacc.2019.02.018.
Risk factors for type 1 and type 2 myocardial infarction.
Wereski R, Kimenai DM, Bularga A, Taggart C, Lowe DJ, Mills NL, Chapman AR.
Eur Heart J. 2022 Jan 13;43(2):127-135. doi: 10.1093/eurheartj/ehab581.
Revisiting type 2 myocardial infarction: Unmet clinical needs.
Palermi A, Saraullo S, Giordano MB, Ricci F, Gallina S, Renda G.
Curr Probl Cardiol. 2025 Oct;50(10):103148. doi: 10.1016/j.cpcardiol.2025.103148. Epub 2025 Aug 7.
The Pathophysiology of Myocardial Ischemia and Perioperative Myocardial Infarction.
Smit M, Coetzee AR, Lochner A.
J Cardiothorac Vasc Anesth. 2020 Sep;34(9):2501-2512. doi: 10.1053/j.jvca.2019.10.005. Epub 2019 Oct 9.
Type 1, Type 2 Myocardial Infarction and Non-Ischemic Myocardial Injury-Opinion from the Front Lines.
Alpert JS, Jaffe AS, White HD, Thygesen KA.
Am J Med. 2022 Aug;135(8):935-938. doi: 10.1016/j.amjmed.2022.03.004. Epub 2022 Mar 25.
Impact of sodium-glucose transport protein-2 (SGLT2) inhibitors on the inflammasome pathway in acute myocardial infarction in type 2 diabetes mellitus: a comprehensive review.
Yoo TT, Baek IH, Stoletniy L, Hilliard A, Sakr A, Doycheva D.
Cardiovasc Diabetol. 2025 May 26;24(1):227. doi: 10.1186/s12933-025-02777-7.
Association of haptoglobin phenotype with incident acute myocardial infarction in Chinese patients with type 2 diabetes.
Gurung RL, Yiamunaa M, Liu S, Liu JJ, Chan C, Choo RWM, Ang K, Sum CF, Tavintharan S, Lim SC.
Cardiovasc Diabetol. 2019 May 30;18(1):65. doi: 10.1186/s12933-019-0867-4.
Myocardial Infarction Type 2: Avoiding Pitfalls and Preventing Adverse Outcomes.
Siddiqui MU, Ahmed A, Siddiqui MD, Pasha AK.
Clin Med Res. 2020 Dec;18(4):117-119. doi: 10.3121/cmr.2020.1574. Epub 2020 Oct 14.
